The retail tranche of the Shanghai-based company’s HK$1.37 billion (US$176 million) IPO handily beat the 90.8 times subscription interest seen in vaccines developer Cansino Biologics’ offering in ... ( read original story ...)
China’s central bank adviser says U.S. tariffs could cut GDP growth by 0.3 percentage points
SHANGHAI (Reuters) - Plans by Washington to hike tariffs on $200 billion of Chinese goods could cut China's growth by 0.3 percentage points but the strengthening economy has become more resilient to ... ( read original story ...)
Chinese stock market rebounds Friday
The Chinese stock market rebounded Friday as the market recovered from previous overreactions, analysts said. The benchmark Shanghai Composite Index closed 3.10 percent higher at 2939.21 points, while ... ( read original story ...)
U.S. stock futures slide after Trump’s tariff increase takes effect
U.S. stock futures fell and Asian shares pared gains on Friday ... “Should tensions escalate significantly in coming days, we expect a pronounced market reaction. There is the potential for a 15%-plus ... ( read original story ...)
Viva Extends Hong Kong Biotech Fever in City’s Hottest 2019 IPO
The Shanghai-based company lured retail investors with orders ... The institutional tranche of the IPO was “significantly oversubscribed,” Viva said in a filing, without providing more details. Viva ... ( read original story ...)
China’s gag on Trump tweets raises doubts about its global market ambitions
SHANGHAI/BEIJING (Reuters ... However many retail investors, who make up roughly 80 percent of China's stock market turnover, did not know what was behind the local equities plunge until much later in ... ( read original story ...)
Chinese stock markets tumble after Trump threatens new tariffs
Chinese stock markets tumbled on Monday after Donald Trump threatened ... Hong Kong’s Hang Seng index dropped 3.1 per cent following Mr Trump’s tweet, while the Shanghai Composite fell by nearly 6 per ... ( read original story ...)